Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity.

Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines.

《Phytomedicine》是一本由ELSEVIER GMBH出版商出版的专业医学期刊，该刊创刊于1994年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 2区，小类学科：全科医学与补充医学 1区；药学 1区；植物科学 1区；药物化学 2区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖药物化学等领域，旨在及时、准确、全面地报道国内外药物化学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为6.656，平均审稿速度约3.0个月。